Literature DB >> 27900027

Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells.

Cui-Juan Qian1, Yi-Yi Chen2, Xin Zhang3, Fu-Qiang Liu2, Ting-Ting Yue2, Bei Ye3, Jun Yao2.   

Abstract

Overexpression of Notch4 is associated with a variety of tumor types. Only sparse information exists on Notch4 expression in pancreatic cancer (PC). The present study demonstrated that Notch4 expression was significantly upregulated in PC cell lines compared with a non-transformed pancreatic epithelial cell line, HPDE6c-7. To investigate the possible role of Notch4 in PC cells, an RNA interference approach was used to silence Notch4 expression. The results revealed that small interfering RNA (siRNA) targeting Notch4 significantly impeded the viability, migration and invasion abilities of PC cells in vitro. Downregulation of Notch4 with siRNA sensitized cells to the action of docetaxel. Furthermore, Notch4 downregulation enhanced the inhibition of Akt activation and the fascin expression induced by docetaxel in PC cells. Together, these data provide insight into the function of Notch4 and suggest that Notch4 may represent a new potential target for gene therapy in PC.

Entities:  

Keywords:  Notch4; cell viability; metastasis; pancreatic cancer; siRNA

Year:  2016        PMID: 27900027      PMCID: PMC5103974          DOI: 10.3892/ol.2016.5097

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

Review 1.  Novel therapeutic targets for pancreatic cancer.

Authors:  Shing-Chun Tang; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.

Authors:  Theresa Pluth Yeo
Journal:  Semin Oncol       Date:  2014-12-09       Impact factor: 4.929

3.  NOTCH4 is a potential therapeutic target for triple-negative breast cancer.

Authors:  Iori Nagamatsu; Hideya Onishi; Shojiro Matsushita; Makoto Kubo; Masaya Kai; Akira Imaizumi; Kenji Nakano; Masami Hattori; Yoshinao Oda; Masao Tanaka; Mitsuo Katano
Journal:  Anticancer Res       Date:  2014-01       Impact factor: 2.480

Review 4.  Recent advances in pancreatic cancer: biology, treatment, and prevention.

Authors:  Divya Singh; Ghanshyam Upadhyay; Rakesh K Srivastava; Sharmila Shankar
Journal:  Biochim Biophys Acta       Date:  2015-05-11

5.  Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma.

Authors:  Lin-Can Ding; Lin She; Da-Li Zheng; Qing-Ling Huang; Jin-Feng Wang; Fei-Fei Zheng; You-Guang Lu
Journal:  Oncol Rep       Date:  2010-08       Impact factor: 3.906

6.  Fascin regulates the migration of subventricular zone-derived neuroblasts in the postnatal brain.

Authors:  Martina Sonego; Sangeetha Gajendra; Maddy Parsons; Yafeng Ma; Carl Hobbs; Marc P Zentar; Gareth Williams; Laura M Machesky; Patrick Doherty; Giovanna Lalli
Journal:  J Neurosci       Date:  2013-07-24       Impact factor: 6.167

Review 7.  Advances in pancreatic cancer research: moving towards early detection.

Authors:  Xiang-Yi He; Yao-Zong Yuan
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Phase 1 dose escalation and pharmacokinetic evaluation of oral gemcitabine prodrug (LY2334737) in combination with docetaxel in patients with advanced solid tumors.

Authors:  Ramon Salazar; Serafin Morales; Marta Gil-Martín; Elena Aguirre; Ana Oaknin; Margarita Garcia; Sophie Callies; Enaksha R Wickremsinhe; Karim A Benhadji; Antonio Llombart
Journal:  Cancer Chemother Pharmacol       Date:  2014-04-18       Impact factor: 3.333

9.  Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway.

Authors:  H Ghebeh; S Al-Khaldi; S Olabi; A Al-Dhfyan; F Al-Mohanna; R Barnawi; A Tulbah; T Al-Tweigeri; D Ajarim; M Al-Alwan
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

10.  AKT and 14-3-3 regulate Notch4 nuclear localization.

Authors:  Gopalakrishnan Ramakrishnan; Gantulga Davaakhuu; Wen Cheng Chung; He Zhu; Ajay Rana; Aleksandra Filipovic; Andrew R Green; Azeddine Atfi; Antonio Pannuti; Lucio Miele; Guri Tzivion
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

View more
  8 in total

Review 1.  Taming the Notch Transcriptional Regulator for Cancer Therapy.

Authors:  Luca Tamagnone; Serena Zacchigna; Michael Rehman
Journal:  Molecules       Date:  2018-02-15       Impact factor: 4.411

2.  Nucleolar localization of the Notch4 intracellular domain underpins its regulation of the cellular response to genotoxic stressors.

Authors:  Neetu Saini; Apurva Sarin
Journal:  Cell Death Discov       Date:  2020-02-18

3.  Notch Signaling Pathway in Pancreatobiliary Tumors.

Authors:  Francesca Borlak; Anja Reutzel-Selke; Anja Schirmeier; Julia Gogolok; Ellen von Hoerschelmann; Igor M Sauer; Johann Pratschke; Marcus Bahra; Rosa B Schmuck
Journal:  Medicina (Kaunas)       Date:  2021-01-24       Impact factor: 2.430

4.  Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.

Authors:  Mingzhou Guo; Mengzhe Zhang; Xiaopei Cao; Xiaoyu Fang; Ke Li; Lu Qin; Yuanzhou He; Jianping Zhao; Yongjian Xu; Xiansheng Liu; Xiaochen Li
Journal:  Respir Res       Date:  2022-01-11

5.  Characterization of Lgr5+ Progenitor Cell Transcriptomes after Neomycin Injury in the Neonatal Mouse Cochlea.

Authors:  Shasha Zhang; Yuan Zhang; Pengfei Yu; Yao Hu; Han Zhou; Lingna Guo; Xiaochen Xu; Xiaocheng Zhu; Muhammad Waqas; Jieyu Qi; Xiaoli Zhang; Yan Liu; Fangyi Chen; Mingliang Tang; Xiaoyun Qian; Haibo Shi; Xia Gao; Renjie Chai
Journal:  Front Mol Neurosci       Date:  2017-07-04       Impact factor: 5.639

6.  Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer.

Authors:  Adriana Harbuzariu; Ruben Rene Gonzalez-Perez
Journal:  Oncotarget       Date:  2018-04-06

Review 7.  The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer.

Authors:  Adriana Harbuzariu; Gabriela M Oprea-Ilies; Ruben R Gonzalez-Perez
Journal:  Medicines (Basel)       Date:  2018-07-02

8.  All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.

Authors:  Chi Huu Nguyen; Katharina Bauer; Hubert Hackl; Angela Schlerka; Elisabeth Koller; Anastasiya Hladik; Dagmar Stoiber; Johannes Zuber; Philipp B Staber; Andrea Hoelbl-Kovacic; Louise E Purton; Florian Grebien; Rotraud Wieser
Journal:  Cell Death Dis       Date:  2019-12-10       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.